FOS and ovarian cancer: For instance, it was shown that overexpressing c-FOS ovarian cancer cells had lower selectin ligands sLea and sLex and diminished adhesion to E-selectin, thereby reducing metastasis in an intraperitoneal xenograft mouse model (48).